WASHINGTON, DC, May 11,
2004 (ENS): More than 140 health and public interest groups
are urging Bayer Corporation not to appeal a ruling that upholds
the U.S. Food and Drug Administration's (FDA) ban on the company's
Cipro-like antibiotics for use in poultry.
Bayer has until May 17 to appeal a March ruling by a federal administrative
law judge that upheld the ban.
Federal officials, public health advocates and environmentalists
want the ban to stay in place because the FDA has shown the use
of these drugs to treat chickens reduces the effectiveness of similar
antibiotics in humans.
"The Judge's opinion makes clear that the decision to ban
Baytril is not even remotely a close call," the groups said
in a letter sent to Bayer Chief Executive Office and President Dr.
Attila Molnar. "The Judge's 68-page decision is based on a
formal evidentiary record that included 388 bound volumes containing
more than 1,100 documents, and on cross-examination of experts lasting
for more than a week. Enough is enough."
The FDA first proposed banning the drugs in October 2000.
Chicago based Abbott Laboratories, one of two U.S. producers of
Cipro-like drugs for poultry, complied with the ban, but the other
producer, Bayer, appealed the proposal.
Bayer makes a Cipro-like antibiotic for use in poultry known as
Both Cipro and Baytril are members of the fluoroquinolone class
of antibiotics and are very similar.
The FDA showed that use of Baytril in poultry reduces the effectiveness
of Cipro in treating campylobacter, the most common cause of severe
bacterial food poisoning.
The six major poultry producers have announced that they no longer
use these drugs in chickens produced for human consumption.
Many leading food service companies - including McDonald's, Dairy
Queen, Burger King, Domino's, Hardee's, Wendy's, Popeye's, Subway,
and Bon Appetit - also have stated that they do not purchase chicken
raised with fluoroquinolones.
Although no formal appeal has been launched of the March ruling,
ban advocates worry that Bayer plans to appeal the decision to the
FDA Commissioner, who will then have to review it before affirming
or reversing the administrative law judge's decision.
That process could take months or years, during which time Baytril
would remain on the market.
"In light of Bayer's motto, 'Expertise with Responsibility,'
the responsible action now is to discontinue the manufacture of
Cipro-like drugs for poultry without further procedural delays,"
said the letter, which was signed by 143 groups including the American
College of Preventative Medicine, Physicians for Social Responsibility
and the Union of Concerned Scientists.
Copyright Environment News Service (ENS) 2004. All Rights Reserved.